Manuel Caruso

1.6k total citations
48 papers, 1.3k citations indexed

About

Manuel Caruso is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Manuel Caruso has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Genetics and 15 papers in Oncology. Recurrent topics in Manuel Caruso's work include Virus-based gene therapy research (20 papers), RNA Interference and Gene Delivery (11 papers) and CAR-T cell therapy research (10 papers). Manuel Caruso is often cited by papers focused on Virus-based gene therapy research (20 papers), RNA Interference and Gene Delivery (11 papers) and CAR-T cell therapy research (10 papers). Manuel Caruso collaborates with scholars based in Canada, United States and France. Manuel Caruso's co-authors include David Klatzmann, J L Salzmann, D Houssin, Singh Gagandeep, Yves Panís, Karim Ghani, Pedro O. de Campos‐Lima, Jian Qiao, Sylvine Carrondo Cottin and Milton J. Finegold and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Manuel Caruso

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Caruso Canada 18 713 676 361 290 245 48 1.3k
Richard J. Cristiano United States 24 1.1k 1.6× 1.5k 2.1× 651 1.8× 243 0.8× 156 0.6× 33 2.2k
Denise R. Shaw United States 21 392 0.5× 858 1.3× 298 0.8× 493 1.7× 108 0.4× 34 1.4k
Moanaro Biswas United States 23 550 0.8× 539 0.8× 351 1.0× 300 1.0× 185 0.8× 52 1.3k
Philippe Erbs France 21 894 1.3× 629 0.9× 586 1.6× 196 0.7× 182 0.7× 52 1.4k
Helmut Esche Germany 21 675 0.9× 1.1k 1.6× 461 1.3× 154 0.5× 85 0.3× 51 1.6k
Evelyn M. Karson United States 14 820 1.2× 860 1.3× 423 1.2× 291 1.0× 108 0.4× 25 1.5k
Brian R. Davis United States 25 498 0.7× 985 1.5× 179 0.5× 381 1.3× 120 0.5× 68 1.9k
Marco Bestagno Italy 25 115 0.2× 800 1.2× 552 1.5× 462 1.6× 197 0.8× 51 1.9k
Chun Jeih Ryu South Korea 26 172 0.2× 1.1k 1.6× 430 1.2× 337 1.2× 400 1.6× 78 1.9k
Edwin R. Manuel United States 20 150 0.2× 466 0.7× 468 1.3× 480 1.7× 85 0.3× 39 1.3k

Countries citing papers authored by Manuel Caruso

Since Specialization
Citations

This map shows the geographic impact of Manuel Caruso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Caruso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Caruso more than expected).

Fields of papers citing papers by Manuel Caruso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Caruso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Caruso. The network helps show where Manuel Caruso may publish in the future.

Co-authorship network of co-authors of Manuel Caruso

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Caruso. A scholar is included among the top collaborators of Manuel Caruso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Caruso. Manuel Caruso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caruso, Manuel, et al.. (2025). Electrocatalytic CO2 to CO and Methanol Conversion Using a Molecular Cobalt Corrole Complex. ACS Catalysis. 15(13). 11093–11102. 5 indexed citations
2.
Nowill, Alexandre E., Manuel Caruso, & Pedro O. de Campos‐Lima. (2023). T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets. Frontiers in Immunology. 14. 1133225–1133225. 6 indexed citations
3.
Roy, Sylvie, Karim Ghani, Pedro O. de Campos‐Lima, & Manuel Caruso. (2021). A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein. Virus Research. 295. 198305–198305. 14 indexed citations
4.
Larouche, Danielle, et al.. (2020). Peel Test to Assess the Adhesion Strength of the Dermal–Epidermal Junction in Tissue-Engineered Skin. Tissue Engineering Part C Methods. 26(3). 180–189. 8 indexed citations
5.
Larouche, Danielle, Karim Ghani, Stéphane Larochelle, et al.. (2018). Translating the combination of gene therapy and tissue engineering for treating recessive dystrophic epidermolysis bullosa. European Cells and Materials. 35. 73–86. 11 indexed citations
6.
Ghani, Karim, et al.. (2012). Nilotinib and imatinib inhibit cytarabine cellular uptake: Implications for combination therapy. Leukemia Research. 36(10). 1311–1314. 6 indexed citations
7.
Caruso, Manuel, et al.. (2010). Methanol Induces a Discrete Transcriptional Dysregulation that Leads to Cytokine Overproduction in Activated Lymphocytes. Toxicological Sciences. 117(2). 303–313. 7 indexed citations
8.
Ghani, Karim, Sylvine Carrondo Cottin, Pedro O. de Campos‐Lima, Marie‐Christine Caron, & Manuel Caruso. (2009). Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery. The Journal of Gene Medicine. 11(8). 664–669. 4 indexed citations
10.
Cottin, Sylvine Carrondo, Karim Ghani, & Manuel Caruso. (2008). Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43. Cancer Gene Therapy. 15(12). 823–831. 21 indexed citations
11.
Avila‐Cariño, Javier, et al.. (2007). Rescue of the immunotherapeutic potential of a novel T cell epitope in the Epstein–Barr virus latent membrane protein 2. Virology. 361(2). 253–262. 7 indexed citations
12.
Qiao, Jian, Karim Ghani, & Manuel Caruso. (2007). Diphtheria toxin mutant CRM197 is an inhibitor of protein synthesis that induces cellular toxicity. Toxicon. 51(3). 473–477. 16 indexed citations
13.
Qiao, Jing, Leonor Sánchez‐Pérez, Tim Kottke, et al.. (2006). VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Gene Therapy. 13(20). 1457–1470. 18 indexed citations
15.
Roy, Vincent, Jie Qiao, Pedro O. de Campos‐Lima, & Manuel Caruso. (2004). Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase. Gene Therapy. 12(2). 169–176. 12 indexed citations
16.
Germain, Emmanuelle, Gaëlle Roullin, Jing Qiao, Pedro O. de Campos‐Lima, & Manuel Caruso. (2004). RD114‐pseudotyped retroviral vectors kill cancer cells by syncytium formation and enhance the cytotoxic effect of the TK/GCV gene therapy strategy. The Journal of Gene Medicine. 7(4). 389–397. 7 indexed citations
17.
D’Hondt, Véronique, Jean‐Pascal Machiels, Manuel Caruso, Alexander Bank, & Michel Symann. (1997). Chemoresistance in hematopoietic cells by retroviral gene transfer of the multidrug resistance-associated protein (MRP) cDNA.. Experimental Hematology. 25(8). 8.
18.
Caruso, Manuel, et al.. (1997). Efficient retroviral gene transfer of a Tat-regulated herpes simplex virus thymidine kinase gene for HIV gene therapy. Virus Research. 52(2). 133–143. 7 indexed citations
19.
Caruso, Manuel. (1996). Gene therapy against cancer and HIV infection using the gene encoding herpes simplex virus thymidine kinase. Molecular Medicine Today. 2(5). 212–217. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026